BD is thrilled to welcome you to IPVC 2024
and extend a special invitation to our exclusive symposium:
Self-sampling and new technologies: achieving equity and elimination of cervical cancer
Join us on Wednesday, November 13th, 12:20-13:30 for this enlightening session in the Sidlaw Auditorium
Boxed lunch will be served.
Cervical cancer screening is at a global inflexion point, with self-collection increasingly being adopted in national screening programs to reach underserved patients or as the primary collection method. Self-collection is also endorsed by the WHO as part of the global cervical cancer elimination initiative. Countries who have adopted self-collection often report rapid growth because of its ability to be deployed in remote locations, ease of use for the patient, and preference over the more invasive pelvic exam collection. Despite these successes, the path to implementation can present challenges with respect to communication, deployment and follow-up of HPV positive patients.
This session will focus on real-world experience with self-collection in a variety of settings.
- Dr. Jeff Andrews will discuss progress in the US with FDA-approved self-collection in a healthcare setting, and the SHIP trial, which is designed to support efforts to bring self-collection into the home.
- Dr. Richard Massey will discuss their experience in New Zealand where self-collection now represents the majority of samples tested.
- Finally, Dr. Natascha Ortiz will discuss self-collection in remote regions of Colombia.
The session will also feature an interactive Q&A session which will provide the opportunity to interact directly with the expert panel.
Fill out the below form to learn more about BD Onclarity™ HPV assay and meet one of our experts at booth #2.
Meet the speakers:
![]() |
![]() |
![]() |
![]() |
|
Athena Lamnisos |
Dr. Richard Massey |
Dr. Natascha Ortiz |
Dr. Jeff Andrews |





BD Onclarity™ HPV Assay for BD COR™ is an in vitro diagnostic medical device bearing a CE mark and is CE certified by BSI Group The Netherlands B.V. (Notified Body Number = 2797).